Randy Fenrick

1.2k total citations
16 papers, 1.1k citations indexed

About

Randy Fenrick is a scholar working on Molecular Biology, Virology and Oncology. According to data from OpenAlex, Randy Fenrick has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Virology and 4 papers in Oncology. Recurrent topics in Randy Fenrick's work include HIV Research and Treatment (5 papers), Heart Failure Treatment and Management (3 papers) and HIV/AIDS drug development and treatment (3 papers). Randy Fenrick is often cited by papers focused on HIV Research and Treatment (5 papers), Heart Failure Treatment and Management (3 papers) and HIV/AIDS drug development and treatment (3 papers). Randy Fenrick collaborates with scholars based in United States, Canada and United Kingdom. Randy Fenrick's co-authors include Michael H. Malim, Bryan R. Cullen, Joachim Hauber, Scott W. Hiebert, Lilin Wang, Joseph M. Amann, James Kamine, Jacob V. Maizel, David M. Markovitz and Shu‐Yun Le and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Randy Fenrick

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randy Fenrick United States 12 594 457 226 222 144 16 1.1k
Kasinath Viswanathan United States 16 431 0.7× 468 1.0× 467 2.1× 215 1.0× 446 3.1× 26 1.3k
Paula Ladne United States 8 562 0.9× 161 0.4× 131 0.6× 77 0.3× 65 0.5× 10 951
Akiko Takeda Japan 23 557 0.9× 639 1.4× 722 3.2× 266 1.2× 232 1.6× 53 1.4k
Najet Rebaï France 19 387 0.7× 486 1.1× 1.2k 5.5× 242 1.1× 159 1.1× 26 1.8k
Robert C. Penhallow United States 8 296 0.5× 406 0.9× 295 1.3× 226 1.0× 135 0.9× 12 790
F Vignaux France 13 361 0.6× 381 0.8× 634 2.8× 205 0.9× 156 1.1× 20 1.1k
Andrew F. Calman United States 8 626 1.1× 513 1.1× 530 2.3× 217 1.0× 88 0.6× 9 1.3k
Sandra K. Ruscetti United States 20 479 0.8× 231 0.5× 420 1.9× 86 0.4× 136 0.9× 53 1.1k
Meisheng Zhou United States 14 1.4k 2.4× 420 0.9× 267 1.2× 168 0.8× 69 0.5× 14 1.7k
L Bergeron United States 10 790 1.3× 477 1.0× 347 1.5× 274 1.2× 214 1.5× 15 1.3k

Countries citing papers authored by Randy Fenrick

Since Specialization
Citations

This map shows the geographic impact of Randy Fenrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Fenrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Fenrick more than expected).

Fields of papers citing papers by Randy Fenrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy Fenrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Fenrick. The network helps show where Randy Fenrick may publish in the future.

Co-authorship network of co-authors of Randy Fenrick

This figure shows the co-authorship network connecting the top 25 collaborators of Randy Fenrick. A scholar is included among the top collaborators of Randy Fenrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy Fenrick. Randy Fenrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Irvin, Brenda J., Lauren D. Wood, Lilin Wang, et al.. (2003). TEL, a Putative Tumor Suppressor, Induces Apoptosis and Represses Transcription of Bcl-XL. Journal of Biological Chemistry. 278(47). 46378–46386. 27 indexed citations
2.
Fenrick, Randy, Lilin Wang, John Nip, et al.. (2000). TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1. Molecular and Cellular Biology. 20(16). 5828–5839. 92 indexed citations
3.
Marquis, Martin, et al.. (1999). Comparative binding study of rat natriuretic peptide receptor-A. Molecular and Cellular Biochemistry. 194(1-2). 23–30. 7 indexed citations
4.
Fenrick, Randy, Joseph M. Amann, Bart Lutterbach, et al.. (1999). Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein. Molecular and Cellular Biology. 19(10). 6566–6574. 134 indexed citations
5.
Fenrick, Randy, et al.. (1998). Characterization of the phosphorylation state of natriuretic peptide receptor-C. Molecular and Cellular Biochemistry. 178(1-2). 95–101. 4 indexed citations
6.
Fenrick, Randy & Scott W. Hiebert. (1998). Role of histone deacetylases in acute leukemia. Journal of Cellular Biochemistry. 72(S30-31). 194–202. 57 indexed citations
7.
Fenrick, Randy & Scott W. Hiebert. (1998). Role of histone deacetylases in acute leukemia. Journal of Cellular Biochemistry. 72(S3031). 194–202. 2 indexed citations
8.
Fenrick, Randy, Nathalie Bouchard, Normand McNicoll, & André De Léan. (1997). Glycosylation of asparagine 24 of the natriuretic peptide receptor-B is crucial for the formation of a competent ligand binding domain. Molecular and Cellular Biochemistry. 173(1-2). 25–32. 26 indexed citations
9.
Fenrick, Randy, et al.. (1996). The human 5-hydroxytryptamine 1A receptor differentially modulates phospholipase c and adenylyl cyclase activities. General Pharmacology The Vascular System. 27(2). 263–268. 7 indexed citations
10.
Fenrick, Randy, Normand McNicoll, & André De Léan. (1996). Glycosylation is critical for natriuretic peptide receptor-B function. Molecular and Cellular Biochemistry. 165(2). 103–109. 27 indexed citations
11.
Fenrick, Randy, et al.. (1994). Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor R1c subtype). Molecular and Cellular Biochemistry. 137(2). 173–182. 21 indexed citations
12.
Fenrick, Randy, Michael H. Malim, Joachim Hauber, et al.. (1989). Functional analysis of the Tat trans activator of human immunodeficiency virus type 2. Journal of Virology. 63(12). 5006–5012. 57 indexed citations
13.
Malim, Michael H., et al.. (1989). Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.. Proceedings of the National Academy of Sciences. 86(21). 8222–8226. 87 indexed citations
14.
Malim, Michael H., Randy Fenrick, Dean W. Ballard, et al.. (1989). Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. Journal of Virology. 63(8). 3213–3219. 43 indexed citations
15.
Malim, Michael H., Joachim Hauber, Randy Fenrick, & Bryan R. Cullen. (1988). Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature. 335(6186). 181–183. 343 indexed citations
16.
Kenney, Shannon C., James Kamine, David M. Markovitz, Randy Fenrick, & Joseph S. Pagano. (1988). An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.. Proceedings of the National Academy of Sciences. 85(5). 1652–1656. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kasinath Viswanathan Breakdown of academic impact, for papers by Paula Ladne Breakdown of academic impact, for papers by Akiko Takeda Breakdown of academic impact, for papers by Najet Rebaï Breakdown of academic impact, for papers by Robert C. Penhallow Breakdown of academic impact, for papers by F Vignaux Breakdown of academic impact, for papers by Andrew F. Calman Breakdown of academic impact, for papers by Sandra K. Ruscetti Breakdown of academic impact, for papers by Meisheng Zhou Breakdown of academic impact, for papers by L Bergeron
Rankless by CCL
2026